Bristol-Myers Squibb sell Morgan Stanley
Start price
19.07.23
/
50%
€55.70
Target price
19.07.24
€52.70
Performance (%)
-30.56%
End price
20.07.24
€38.68
Summary
This prediction ended on 20.07.24 with a price of €38.68. The SELL prediction by Morgan_Stanley for Bristol-Myers Squibb performed very well with a performance of -30.56%. Morgan_Stanley has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Sell. A total of €2.19 was paid as dividends for this prediction. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 3.575% | 3.575% | 38.175% | -0.035% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% | 65.211% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% | 90.325% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% | 80.623% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% | 70.737% |
Comments by Morgan_Stanley for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $59.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Bristol-Myers Squibb
Stopped prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.13
10.07.25
10.07.25
€28.95
10.07.26
10.07.26
21.95%
11.07.26
11.07.26
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€56.01
12.11.24
12.11.24
€36.70
12.11.25
12.11.25
-23.83%
13.11.25
13.11.25
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.80
27.10.23
27.10.23
€47.31
27.10.24
27.10.24
-3.66%
28.10.24
28.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
11.10.23
11.10.23
€52.70
11.10.24
11.10.24
-11.04%
12.10.24
12.10.24